跳至主要内容
临床试验/IRCT20220903055865N1
IRCT20220903055865N1招募中未知

The Comparison of the effectiveness of Piroxicam mesotherapy versus Using Extracorporeal Shock Wave Therapy (ESWT) in Reducing Pain and Improving Function in Patients with rotator caff tendinopathy

Shiraz University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Completing and signing the consent form
  • Patients with shoulder pain lasting more than 4 weeks
  • Shoulder pain with an Oxford shoulder score of at least 4 in the last month
  • Age over 18
  • Absence of any type of disease around the relevant joint

排除标准

  • Any pathology found on the plain radiograph, including degenerative findings of the shoulder joint
  • Any clinical symptoms of effusion, inflammation, redness and warmth of the shoulder
  • Having diabetes, uncontrolled blood pressure and rheumatic and vascular collagen diseases such as lupus, gout and simultaneous radiculopathy, myopathy, nerve damage and neuropathies such as carpal tunnel syndrome, stroke and any type of systemic infection.
  • Body mass index above 42
  • History of joint replacement and trauma and fracture on the side of the involved shoulder
  • Suffering from bleeding diseases and taking anticoagulant drugs
  • Psychological problems
  • Any hypersensitivity to drugs used in the study, such as piroxicam
  • History of significant heart, kidney, liver, brain, lung disorders
  • History of injections in or around the affected shoulder joint in the last 3 months
  • History of shoulder and upper limb physiotherapy in the last one month
  • Pregnant and lactating woman

研究者

相似试验